1. Home
  2. BLFS vs OCSL Comparison

BLFS vs OCSL Comparison

Compare BLFS & OCSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFS
  • OCSL
  • Stock Information
  • Founded
  • BLFS 1987
  • OCSL 2007
  • Country
  • BLFS United States
  • OCSL United States
  • Employees
  • BLFS N/A
  • OCSL N/A
  • Industry
  • BLFS Medical/Dental Instruments
  • OCSL Finance: Consumer Services
  • Sector
  • BLFS Health Care
  • OCSL Finance
  • Exchange
  • BLFS Nasdaq
  • OCSL Nasdaq
  • Market Cap
  • BLFS 1.2B
  • OCSL 1.2B
  • IPO Year
  • BLFS 1989
  • OCSL 2008
  • Fundamental
  • Price
  • BLFS $23.29
  • OCSL $13.79
  • Analyst Decision
  • BLFS Strong Buy
  • OCSL Hold
  • Analyst Count
  • BLFS 7
  • OCSL 7
  • Target Price
  • BLFS $30.57
  • OCSL $16.00
  • AVG Volume (30 Days)
  • BLFS 573.8K
  • OCSL 723.5K
  • Earning Date
  • BLFS 05-08-2025
  • OCSL 05-01-2025
  • Dividend Yield
  • BLFS N/A
  • OCSL 14.45%
  • EPS Growth
  • BLFS N/A
  • OCSL N/A
  • EPS
  • BLFS N/A
  • OCSL 0.11
  • Revenue
  • BLFS $87,762,000.00
  • OCSL $353,866,000.00
  • Revenue This Year
  • BLFS $20.32
  • OCSL N/A
  • Revenue Next Year
  • BLFS $19.98
  • OCSL $1.34
  • P/E Ratio
  • BLFS N/A
  • OCSL $130.19
  • Revenue Growth
  • BLFS N/A
  • OCSL N/A
  • 52 Week Low
  • BLFS $17.15
  • OCSL $12.50
  • 52 Week High
  • BLFS $29.55
  • OCSL $19.80
  • Technical
  • Relative Strength Index (RSI)
  • BLFS 49.30
  • OCSL 44.46
  • Support Level
  • BLFS $21.13
  • OCSL $13.26
  • Resistance Level
  • BLFS $25.60
  • OCSL $13.76
  • Average True Range (ATR)
  • BLFS 1.58
  • OCSL 0.31
  • MACD
  • BLFS -0.07
  • OCSL -0.01
  • Stochastic Oscillator
  • BLFS 48.32
  • OCSL 36.93

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

Share on Social Networks: